US Stock MarketDetailed Quotes
ELV Elevance Health
- 534.810
- -3.940-0.73%
Close Jun 14 16:00 ET
- 535.220
- +0.410+0.08%
Post 18:52 ET
124.30BMarket Cap20.17P/E (TTM)
538.080High531.635Low584.31KVolume536.760Open538.750Pre Close312.22MTurnover0.25%Turnover Ratio21.21P/E (Static)232.42MShares549.99052wk High3.06P/B123.99BFloat Cap406.80952wk Low6.07Dividend TTM231.84MShs Float549.990Historical High1.13%Div YieldTTM1.20%Amplitude16.546Historical Low534.345Avg Price1Lot Size
Elevance Health Stock Forum
Sign in to post a comment
RECAP
April rain better mean the stock market stops the pain by May: the market declined Tuesday, punctuated by the fall of fan favorite Tesla. The EV maker made less EV's than last year and dropped nearly 5%.
Stocks closed lower, the $S&P 500 Index(.SPX.US$ was recently down about 0.72%. $NASDAQ 100 Index(.NDX.US$ fell about 0.94%. $Dow Jones Industrial Average(.DJI.US$ fell 1%.
MACRO
Job openings recorded by JOLTS were just shy of expectations...
April rain better mean the stock market stops the pain by May: the market declined Tuesday, punctuated by the fall of fan favorite Tesla. The EV maker made less EV's than last year and dropped nearly 5%.
Stocks closed lower, the $S&P 500 Index(.SPX.US$ was recently down about 0.72%. $NASDAQ 100 Index(.NDX.US$ fell about 0.94%. $Dow Jones Industrial Average(.DJI.US$ fell 1%.
MACRO
Job openings recorded by JOLTS were just shy of expectations...
42
4
High insider ownership aligns management incentives with shareholders, but recent insider share sales, especially below current price, are concerning. Lack of insider purchases over the last year adds to the unease.
1
Market optimism grows for the stock after years of progress. Despite slowing share price gains, the business may continue to execute with prowess.
Elevance Health's performance is commendable, particularly its high rate of return and significant reinvestment into its business, which has led to impressive earnings growth. Analysts expect the company's earnings to gain momentum in the future.
Elevance's 2024 earnings guidance and cost control in its Medicare business may reassure investors. CEO Gail Boudreaux expects improved earnings in the Medicare business in 2024.
Despite a decline in membership base, Elevance's financial performance and future guidance indicate a positive outlook. The company's ability to raise its dividend and report significant YoY growth in operating revenue, despite industry challenges, suggests strong financial management and resilience.
1
1
3
RECAP
Investors Weigh Risks
US stocks once again closed little changed Friday as investors weighed positive inflation signs from the latest producer price index against the warnings gleaned from banks and other companies which were among the first to report fourth-quarter earnings.
The $S&P 500 Index(.SPX.US$ closed less than 0.1% higher, while the $Nasdaq Composite Index(.IXIC.US$ ended almost flat for the ...
Investors Weigh Risks
US stocks once again closed little changed Friday as investors weighed positive inflation signs from the latest producer price index against the warnings gleaned from banks and other companies which were among the first to report fourth-quarter earnings.
The $S&P 500 Index(.SPX.US$ closed less than 0.1% higher, while the $Nasdaq Composite Index(.IXIC.US$ ended almost flat for the ...
17
$UnitedHealth(UNH.US$ reported a higher-than-expected spending on patients' healthcare services in the fourth quarter, sending its stock and that of its peers lower.
UnitedHealth said the company's medical care ratio, which measures medical expenses paid as a percentage of insurance premiums, reached 85% in the fourth quarter. That's higher than the 84.1% expected by analysts surveyed by FactSet, according to a Dow Jon...
UnitedHealth said the company's medical care ratio, which measures medical expenses paid as a percentage of insurance premiums, reached 85% in the fourth quarter. That's higher than the 84.1% expected by analysts surveyed by FactSet, according to a Dow Jon...
2
Spencer Moore and Anthony Mollica attribute Paragon's growth to Peak Rock's strategic and operational resources. They consider the transaction as a testament to Peak Rock's expertise in fostering the growth of family and founder-owned businesses.
1
No comment yet
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
binjh : Well, they do say sell in May and go away.
Power Bull : Good update. Keep it coming
eldritch : market is bleeding right now bears got it on lock for now it can only rise
KL6808 : Bear trap, value trap or whatsoever, I belong to the old school where only death and taxes are certain.
If history always repeat itself, then no one will lose a dime.
Ask yourself what you are, intraday, medium, long term trader, what are your core holdings and what are your tactical, speculative bets?
It's always good to take some money off the table if the underlying hit their ATH. If you ain't so lucky as some are approaching their ATL, then should you cut some losses?
Meanwhile, some guru, big fund managers are talking about three rate cuts this year, but don't bet on it that they will come soon. Even if they do, or if the cuts are more than 25bp, then you better be worried that FED might have seen something coming, eg a worst off recession and a potential harder landing than the markets expect.